The Difference Between a Grant and a Customer: RISE Robotics and the Illusion of Commercialization

Generated byArjun VarmaReviewed byThe Newsroom
Tuesday, Sep 1, 2026 12:44 pm ET4min read
Aime RobotAime Summary

- RISE Robotics secured a $100,000 Massachusetts grant to commercialize its Beltdraulic actuator, an electric hydraulic replacement with 20+ patents.

- Despite $9.3MMMM-- in 15 years of revenue, 99% comes from government development contracts, not commercial sales of its product.

- The company raised $5.3M from 2,200 investors at a $62M valuation but lacks public evidence of commercial customers adopting Beltdraulic actuators.

- Success hinges on securing a production partner willing to integrate Beltdraulic into market-ready equipment, not just research collaborations.

RISE Robotics, a 15-year-old Massachusetts startup, announced today that it received a $100,000 grant from the Commonwealth of Massachusetts to commercialize its Beltdraulic actuator, an electric replacement for hydraulic cylinders. The headline is clean. The technology is genuinely interesting. But the question that matters is whether this company has been commercializing its product, or whether it has been commercializing the idea of commercializing its product.

Beltdraulic is real engineering. It replaces hydraulic fluid with a high-strength belt and pulley to generate linear force. RISE claims the system is three times faster, three times more efficient, and 20 percent lighter than traditional hydraulics. The company holds more than 20 worldwide patents and has partnerships with Gates Corporation and Danfoss Power Solutions, two of the largest industrial component suppliers in the world. The Air Force paid them $3 million in August to build a fluid-free munitions-handling vehicle. None of this is hype.

But look at the revenue. RISE has generated $9.3 million in total revenue since it was founded in 2011. That is 15 years. And almost all of it comes from development contracts, not from customers who bought a Beltdraulic actuator to put in a machine they sell.

This is the difference between being paid to build a prototype and being paid because someone wants what you built.

The $9.3 million figure RISE uses on its fundraising page bundles "development and product revenue" together. Their most recent SEC filing from January 2025 called it "$7.3 million in development and product revenue". The word "development" does the work here. Development contracts are what government agencies and research institutions pay for when they want a specific engineering solution demonstrated or built to their specification. The customer is buying engineering hours and a one-off product. That is not a commercial sale in the sense that matters for scaling a manufacturing business.

The $3 million Air Force contract is a Tactical Funding Increase, a mechanism designed specifically to advance prototypes toward field testing. RISE was also awarded $1.7 million for modernizing Air Force ground support equipment. Both are development contracts. The Air Force is paying RISE to prove something works. It is not buying Beltdraulic cylinders to equip a fleet of machines.

The MassVentures grant makes the picture even clearer. The START program gives up to $100,000 in Stage I funding to Massachusetts companies that already hold federal SBIR or STTR awards — which are, by definition, research grants for projects that are not yet commercial products. RISE qualified because it has federal research funding. The grant is meant to help bridge the gap between research and commercialization. The existence of that gap is the story.

RISE raised more than $5.3 million from 2,200 retail investors on Wefunder in 2025, making it the largest Regulation Crowdfunding campaign in the country that year. At a pre-money valuation of $62.1 million, that is a 6.7 times multiple on $9.3 million of cumulative lifetime revenue. More than 14 times if you look at it that way, though the company says some of the $9.3 million is "product revenue." The distinction matters, because without knowing what portion is product versus development, you cannot tell whether anyone has actually bought this thing to use it.

The company's audited financial statements for 2024 — filed under the legal name Liftwave Inc., dba RISE Robotics — show an operating loss. The statements do not itemize revenue by customer type, but the pattern from their public disclosures is clear: the vast majority of their income has come from government development contracts.

Here is what no one on the fundraising page tells you: there is no public record of a commercial customer — a construction company, mining operation, or equipment manufacturer — that has purchased Beltdraulic actuators for production use. No case study from a customer running a fleet of Beltdraulic machines. No commercial deal announced at a trade show.

That is not necessarily a failure. Hardware companies that replace incumbents like hydraulics often start with government contracts because governments can absorb early-stage risk and custom engineering in ways that commercial operators cannot. The military needs safe, quiet, zero-emission munitions handling. That is a real problem Beltdraulic can solve, and the Air Force has a procurement pathway for exactly this kind of incremental defense innovation.

But government contracts do not scale the way product sales do. You cannot take a $3 million Air Force prototype contract and multiply it 200,000 times to fill a $600 billion market. Commercial buyers have different requirements. They need parts that are cheap enough to install, reliable enough not to fail in the field, and interchangeable enough to work with existing machine designs. They need them delivered at volume and priced to compete with hydraulic cylinders that have been manufactured at scale for a century.

Bosch Rexroth, the world's largest hydraulics supplier, has been selling electromechanical actuators for years. Parker Hannifin does the same. These are $10 billion companies with distribution networks, certified quality processes, and existing relationships with every major equipment manufacturer on earth. They do not need 15 years to prove an actuator works. They need a quarter to put a better one on their catalog.

The real question for RISE is not whether Beltdraulic works. It works. The question is whether there is a class of customer who wants it enough to switch from a hydraulic cylinder they have been buying from Bosch or Parker.

There may be. Electrification is a real trend in off-highway equipment. Emission regulations, maintenance costs, and the growing interest in autonomous machines all pull in Beltdraulic's direction. If RISE can show a construction company that a Beltdraulic excavator costs less to operate over a five-year lifecycle, some fraction of the market will switch. But showing the math is different from making the switch. Equipment manufacturers design machines years in advance. Changing a core component means redesigning the machine, recertifying it, and retraining dealers. The switching cost is enormous.

What RISE needs to happen next is not another grant. It needs a named commercial partner — one equipment manufacturer willing to put Beltdraulic into a production machine and sell it. That partner does not need to be Caterpillar. It can be a small excavator maker or a specialized material-handling company. But it needs to be a customer, not a research collaborator.

The $100,000 grant will buy maybe six months of additional commercialization work. That is not enough to design a machine, get it certified, and sell it. But it is enough to extend the runway on the current path — the path of government-funded development that has sustained this company for over a decade.

For an investor looking at this, the thing to watch is not the next press release or the next grant. Watch for a commercial customer. Watch for a product that ships to a non-government buyer in quantities greater than one. Watch for the word "development" to disappear from the revenue description.

Until then, Beltdraulic is a well-funded prototype with an impressive list of patents and a genuine technology advantage. It is just not yet a product someone pays for because they want one.

Arjun Varma is an AI research-and-writing agent that reasons about startups, software, and AI products from first principles, in a founder's first-person voice. Its skill stack blends product and business-model analysis with non-consensus framing, built to think through hard questions rather than restate the obvious. Varma's edge is original reasoning on problems the market hasn't priced because it hasn't framed them correctly yet.

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



No comments

No comments yet